Features

Transitions Announces Dates for Transitions Academy 2023

Transitions has announced that Transitions Academy 2023 will be held from May 21 to 24, 2023 at the JW Marriott Grande Lakes in Orlando, Fla.

FBC Recognizes World Glaucoma Week

Fighting Blindness Canada (FBC) is marking World Glaucoma Week, March 12 – 18, 2023, with activities to raise awareness of glaucoma, the leading cause of preventable, irreversible blindness worldwide that impacts over 725,000 Canadians.

OGS Issues Call for 2023 Grant Applications

Optometry Giving Sight (OGS) has opened the call for applications for its 2023 grant cycle.

EssilorLuxottica Presents Leonardo: Open Learning Platform

Expert content from EssilorLuxottica available 24/7 to employees, eye care professionals, patients, and the public

FBC Continues to Call for Coverage of Sight-Saving Treatment after Ontario Becomes Fourth Province to Sign Agreement

Fighting Blindness Canada (FBC) is pleased to hear Ontario has approved public coverage of Luxturna® (generic name: voretigene neparvovec-rzyl).

1 93 94 95 96 97 443

Transitions Announces Dates for Transitions Academy 2023

Transitions has announced that Transitions Academy 2023 will be held from May 21 to 24, 2023 at the JW Marriott Grande Lakes in Orlando, Fla.

FBC Recognizes World Glaucoma Week

Fighting Blindness Canada (FBC) is marking World Glaucoma Week, March 12 – 18, 2023, with activities to raise awareness of glaucoma, the leading cause of preventable, irreversible blindness worldwide that impacts over 725,000 Canadians.

OGS Issues Call for 2023 Grant Applications

Optometry Giving Sight (OGS) has opened the call for applications for its 2023 grant cycle.

EssilorLuxottica Presents Leonardo: Open Learning Platform

Expert content from EssilorLuxottica available 24/7 to employees, eye care professionals, patients, and the public

FBC Continues to Call for Coverage of Sight-Saving Treatment after Ontario Becomes Fourth Province to Sign Agreement

Fighting Blindness Canada (FBC) is pleased to hear Ontario has approved public coverage of Luxturna® (generic name: voretigene neparvovec-rzyl).

1 93 94 95 96 97 443

Transitions Announces Dates for Transitions Academy 2023

Transitions has announced that Transitions Academy 2023 will be held from May 21 to 24, 2023 at the JW Marriott Grande Lakes in Orlando, Fla.

FBC Recognizes World Glaucoma Week

Fighting Blindness Canada (FBC) is marking World Glaucoma Week, March 12 – 18, 2023, with activities to raise awareness of glaucoma, the leading cause of preventable, irreversible blindness worldwide that impacts over 725,000 Canadians.

OGS Issues Call for 2023 Grant Applications

Optometry Giving Sight (OGS) has opened the call for applications for its 2023 grant cycle.

EssilorLuxottica Presents Leonardo: Open Learning Platform

Expert content from EssilorLuxottica available 24/7 to employees, eye care professionals, patients, and the public

FBC Continues to Call for Coverage of Sight-Saving Treatment after Ontario Becomes Fourth Province to Sign Agreement

Fighting Blindness Canada (FBC) is pleased to hear Ontario has approved public coverage of Luxturna® (generic name: voretigene neparvovec-rzyl).

1 93 94 95 96 97 443

Transitions Announces Dates for Transitions Academy 2023

Transitions has announced that Transitions Academy 2023 will be held from May 21 to 24, 2023 at the JW Marriott Grande Lakes in Orlando, Fla.

FBC Recognizes World Glaucoma Week

Fighting Blindness Canada (FBC) is marking World Glaucoma Week, March 12 – 18, 2023, with activities to raise awareness of glaucoma, the leading cause of preventable, irreversible blindness worldwide that impacts over 725,000 Canadians.

OGS Issues Call for 2023 Grant Applications

Optometry Giving Sight (OGS) has opened the call for applications for its 2023 grant cycle.

EssilorLuxottica Presents Leonardo: Open Learning Platform

Expert content from EssilorLuxottica available 24/7 to employees, eye care professionals, patients, and the public

FBC Continues to Call for Coverage of Sight-Saving Treatment after Ontario Becomes Fourth Province to Sign Agreement

Fighting Blindness Canada (FBC) is pleased to hear Ontario has approved public coverage of Luxturna® (generic name: voretigene neparvovec-rzyl).

1 93 94 95 96 97 443